Genetic Screening of Patients with Sporadic Alzheimer’s Disease and Frontotemporal Lobar Degeneration in the Chinese Population
Journal of Alzheimer's Disease · 2024
DOI: 10.3233/jad-231361 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Alzheimer's Disease, 2024. Verfasst von Yaoru Li und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Tianjin Neurological Institute, Tianjin Medical University General Hospital, Heping District, Tianjin, China. Hauptthemen laut MEDLINE: Alzheimer Disease, Frontotemporal Lobar Degeneration, Genetic Testing. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 48 Literaturangaben.
Themen: Demenz
Abstract (Originalsprache)
Background
Alzheimer’s disease (AD) and frontotemporal lobar degeneration (FTLD) account for the vast majority of neurodegenerative dementias. AD and FTLD have different clinical phenotypes with a genetic overlap between them and other dementias.
Objective
This study aimed to identify the genetic spectrum of sporadic AD and FTLD in the Chinese population.
Methods
A total of 74 sporadic AD and 29 sporadic FTLD participants were recruited. All participants underwent whole-exome sequencing (WES) and testing for a hexanucleotide expansion in C9orf72 was additionally performed for participants with negative WES results.
Results
Four known pathogenic or likely pathogenic variants, including PSEN1 (p.G206D), MAPT (p.R5H), LRRK2 (p.W1434*), and CFAP43 (p.C934*), were identified in AD participants, and 1 novel pathogenic variant of ANXA11 (p.D40G) and two known likely pathogenic variants of MAPT (p.D177V) and TARDBP (p.I383V) were identified in FTLD participants. Twenty-four variants of uncertain significance as well as rare variants in risk genes for dementia, such as ABCA7, SORL1, TRPM7, NOS3, MPO, and DCTN1, were also found. Interestingly, several variants in participants with semantic variant primary progressive aphasia were detected. However, no participants with C9orf72 gene variants were found in the FTLD cohort.
Conclusions
There was a high frequency of genetic variants in Chinese participants with sporadic AD and FTLD and a complex genetic overlap between these two types of dementia and other neurodegenerative diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Tianjin Neurological Institute, Tianjin Medical University General Hospital, Heping District, Tianjin, China.
- Department Five of Neurology, Cangzhou Central Hospital, Yunhe District, Cangzhou, Hebei, China.
- College of Life Sciences, University of Chinese Academy of Sciences, Shijingshan District, Beijing, China.
- Tianjin Medical Laboratory, BGI-Tianjin, BGI-Shenzhen, Tianjin, China.
Zitieren
APA
Li, Y., Yang, Z., Zhang, Y., Liu, F., Xu, J., Meng, Y., Xing, G., Ruan, X., Sun, J., & Zhang, N. (2024). Genetic Screening of Patients with Sporadic Alzheimer’s Disease and Frontotemporal Lobar Degeneration in the Chinese Population. Journal of Alzheimer's Disease. https://doi.org/10.3233/jad-231361
Vancouver
Li Y, Yang Z, Zhang Y, Liu F, Xu J, Meng Y, et al. Genetic Screening of Patients with Sporadic Alzheimer’s Disease and Frontotemporal Lobar Degeneration in the Chinese Population. Journal of Alzheimer's Disease. 2024. doi:10.3233/jad-231361
BibTeX
@article{Li2024,
author = {Li, Yaoru and Yang, Ziying and Zhang, Yanxin and Liu, Fang and Xu, Jing and Meng, Yaping and Xing, Gebeili and Ruan, Xuqin and Sun, Jun and Zhang, Nan},
title = {Genetic Screening of Patients with Sporadic Alzheimer’s Disease and Frontotemporal Lobar Degeneration in the Chinese Population},
journal = {Journal of Alzheimer's Disease},
year = {2024},
doi = {10.3233/jad-231361}
}
EUVIMED